AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC). (Q39775573)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC). |
scientific article |
Statements
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC) (English)
Van Chanh Ngo
Heng Nung Koong
Donald Poon
Han Chong Toh
Choon Hua Thng
Pierce Chow
Hock Soo Ong
Alexander Chung
Boon Cher Goh
Paul D Smith
Khee Chee Soo
28 October 2009